PGR and neoplasm: Traditionally, several parameters are related to the risk of recurrence and to the response to drug therapy, e.g. tumour size, histological grade and proliferation, lymph node involvement, lymphovascular invasion, overexpression and/or amplification of the human epidermal growth factor receptor 2 (Her2) gene and failure to express the oestrogen receptor (ER) and progesterone receptor (PR).